August Monthly Test Update

Published on 08/07/14
Molecular Testing
Test NameTest CodeTest Type
Pan-Ethnic Carrier Screen: Mutation Analysis, Including X-Linked Conditions (With Fragile X Repeat Analysis), and SMA AnalysisMM480Next Generation Sequencing
Pan-Ethnic Carrier Screen: Mutation Analysis, Including X-Linked Conditions (With Fragile X Repeat Analysis)MM481Next Generation Sequencing
Pan-Ethnic Carrier Screen: Mutation and SMA AnalysisMM482Next Generation Sequencing
Pan-Ethnic Carrier Screen: Mutation AnalysisMM483Next Generation Sequencing
Spinal Muscular Atrophy: Carrier ScreenMM490Carrier Screen
Ashkenazi Jewish Carrier Screen: Mutation Analysis, Including Fragile X Repeat Analysis, and SMA AnalysisMM510Next Generation Sequencing
Ashkenazi Jewish Carrier Screen: Mutation Analysis, Including Fragile X Repeat AnalysisMM511Next Generation Sequencing
Ashkenazi Jewish Carrier Screen: Mutation and SMA AnalysisMM512Next Generation Sequencing
Ashkenazi Jewish Carrier Screen: Mutation AnalysisMM513Next Generation Sequencing
Biochemical Testing
Test NameTest CodeTest Type
Sterols, PlasmaBSTRL
Smith-Lemli-Opitz Screen: 7-dehydrocholesterol, PlasmaBSLOS

Recent Test Updates

EGL recently updated the following tests: 

  • MM021 Autism Panel: Tier 2 – Added CHD8 
  • MM320 Severe Combined Immunodeficiency (SCID) B+: Sequencing Panel – Added 5 genes (FOXN1, ORAI1, STIM1, STAT5B, and TBX1

Turnaround Time Update

Please note that all single-gene deletion/duplication tests now have a reduced turnaround time, from 42 days to 28 days.

Test Requisitions - Things to Remember

Not completing a test requisition form entirely can sometimes lead to unnecessary delays in testing. Below are the most commonly missed items:

  • ICD9 codes
  • Policy holder name and date of birth
  • If any authorizations are obtained for the patient, please include a copy of the authorizations with the requisition.
  • Medicare patients must have a signed Advance Beneficiary Notice of Non-coverage (ABN) included with the requisition, except for following BRCA-related test codes: MM070, MM071, MM072, and MM208. Please note, EGL does not pre-verify benefits for patients with Medicare.
  • Signature in the “Authorization to Assign Benefits” section
  • Front and back copy of the patient’s insurance card
  • Billing pages - regardless of the person or entity to be billed, please complete this information.

Prior Authorization Reminder

When it is determined that a prior authorization is needed for testing, the sample will be placed on a billing hold. EGL will notify the client as to what is required and help with any necessary paperwork.

New and Updated Gene Panels

Industry-leading number of gene panels

EGL Next Generation Sequencing Panels include comprehensive, evidence-based gene lists, improved turnaround times, and reduced pricing.